Zacks Investment Management »

Tarsus Pharmaceuticals shares owned by Zacks Investment Management

Quarter-by-quarter ownership of Tarsus Pharmaceuticals (TARS) shares owned by Zacks Investment Management from 13F filings

Historical chart of Zacks Investment Management investment in Tarsus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Tarsus Pharmaceuticals held by Zacks Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tarsus Pharmaceuticals by Zacks Investment Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.0M 15k 70.15

More positions owned by Zacks Investment Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Caterpillar (CAT)
JPMorgan Chase & Co. (JPM)
Wal-Mart Stores (WMT)
Exxon Mobil Corporation (XOM)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Amazon (AMZN)
Johnson & Johnson (JNJ)
Parker-Hannifin Corporation (PH)
Cisco Systems (CSCO)
Abbvie (ABBV)

View all positions for Zacks Investment Management

Top funds holding Tarsus Pharmaceuticals

Deep Track Capital
BlackRock
Rtw Investments
Paradigm Biocapital Advisors
Vanguard Group
Henderson Group
Morgan Stanley
Vanguard Capital Management
Jennison Associates
Assenagon Asset Management
Bank of America Corporation
Tang Capital Management
Driehaus Capital Management
Geode Capital Management
State Street Corporation

View all funds holding Tarsus Pharmaceuticals